Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

μ-opiate receptors in skin cells may affect skin health and healing.

T-cell patterns in skin help distinguish alopecia areata from androgenetic alopecia.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

Catalytic antibodies are early indicators and active participants in the development of systemic lupus erythematosus.

The skin's immune system helps it regenerate and fight infections.

Different γδ T cell types have unique roles in causing alopecia areata.

SARS-CoV-2 proteins help the virus avoid the immune system, delaying response and increasing inflammation.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

Skin problems are common and early signs of Systemic Lupus Erythematosus, and certain immune system markers are important for diagnosis and treatment.

The assay effectively identifies compounds that affect immune cell activation.

Innate lymphoid cells type 1 may contribute to alopecia areata.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

New findings suggest potential treatments for melanoma, hyperpigmentation, hair defects, and multiple sclerosis, and show skin microbiome changes don't cause atopic dermatitis.

Connexin 30 is usually absent in normal skin but can appear in certain skin conditions.

Patients with acute and subacute skin lupus respond faster to belimumab than those with chronic skin lupus.

Certain immune cells may cause hair loss by reacting to stressed hair follicles.

Porcine skin is very similar to human skin, making it a useful model for research.

T cells affect skin cell genes in inflammatory diseases, and therapy can normalize these changes.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

Regulatory T cells adapt to different environments to control inflammation and support tissue repair.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.

Markers CRABP1, Nestin, and Ephrin B2 are present in skin cancer environments and may influence their development.

The surrounding tissue plays a crucial role in the growth and spread of skin cancer.

Psoriasis patients' immune response to a hair protein depends on their specific gene type.

Skin lymphoproliferative disorders are hard to diagnose and often linked to systemic diseases, but most have a good prognosis with accurate diagnosis.